Edition:
United Kingdom

Hansa Medical AB (HMED.ST)

HMED.ST on Stockholm Stock Exchange

207.60SEK
17 Aug 2018
Change (% chg)

3.00kr (+1.47%)
Prev Close
204.60kr
Open
204.60kr
Day's High
209.80kr
Day's Low
203.20kr
Volume
43,090
Avg. Vol
128,398
52-wk High
290.00kr
52-wk Low
158.00kr

Chart for

About

Hansa Medical AB is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection. The Company’s operations consist of research and development for drug discovery. The Company conducts several projects, among which... (more)

Overall

Beta: 1.83
Market Cap(Mil.): kr7,554.32
Shares Outstanding(Mil.): 35.05
Dividend: --
Yield (%): --

Financials

  HMED.ST Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -4.39 -- --
ROI: -83.23 1.78 14.61
ROE: -83.96 3.28 16.33

BRIEF-Hansa Medical Q1 Operating Loss Widens To SEK 46.6 Million

* Q1 OPERATING LOSS SEK 46.6 MILLION VERSUS LOSS SEK 44.8 MILLION YEAR AGO

25 Apr 2018

BRIEF-Hansa Medical Appoints Søren Tulstrup New President And CEO

* SØREN TULSTRUP APPOINTED NEW PRESIDENT AND CEO OF HANSA MEDICAL

20 Mar 2018

Earnings vs. Estimates